Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. Ahn JH, Kim J, Hong SP, Choi SY, et al. J Clin Invest 2021;131.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ahn JH, Kim J, Hong SP, Choi SY, et al. Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19. J Clin Invest 2021;131.
PMID: 34003804